Medpace Inc. (MEDP)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Bid | 319.95 |
Market Cap | 10.79B |
Revenue (ttm) | - |
Net Income (ttm) | - |
EPS (ttm) | 11.42 |
PE Ratio (ttm) | 30.39 |
Forward PE | n/a |
Analyst | Hold |
Ask | 364.52 |
Volume | 179,425 |
Avg. Volume (20D) | 278,905 |
Open | 342.52 |
Previous Close | 343.38 |
Day's Range | 342.52 - 351.45 |
52-Week Range | 293.37 - 459.77 |
Beta | undefined |
About MEDP
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory...
Analyst Forecast
According to 9 analyst ratings, the average rating for MEDP stock is "Hold." The 12-month stock price forecast is $367, which is an increase of 5.74% from the latest price.
Next Earnings Release
Analysts project revenue of ... Unlock content with Pro Subscription